SITE QUALIFICATION PROCESS
OUR COMITMENT TO INNOVATION
A RIGOROUS SITE QUALIFICATION PROCESS
ECLEVAR follows a stringent vetting approach for early phase trial sites (Figure 2). This is based on long-term relationships with a wide network of sites around the world. An analysis of the sites’ scientific, therapeutic, regulatory, site management, and project management experience and expertise helps identify strengths and weaknesses. Each site on the short-list completes a detailed questionnaire about its capabilities and experience.